Neoadjuvant Therapy for Locally Advanced Rectal Cancer With Fruquintinib, Toripalimab and SRT
Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of combined
fruquintinib、toripalimab and SRT in neoadjuvant therapy for locally advanced rectal cancer.